AutoZone Reports Slowing Same-Store Sales Growth in Q2 Amid Persistent Margin Pressures

What happened

AutoZone announced second-quarter fiscal 2026 net sales of $4.3 billion, an 8.1% year-over-year increase, with same-store sales rising 3.3% overall and 3.4% domestically. This represents a deceleration from the first quarter's 5.5% same-store sales growth, hinting at potential demand headwinds or competitive pressures. Despite the top-line growth, the company continues to grapple with margin compression from unfavorable LIFO impacts and SG&A deleverage, as highlighted in recent SEC filings. The DeepValue report emphasizes that AutoZone's stock is significantly overvalued, trading at a 133% premium to a conservative DCF estimate, while carrying high leverage and negative equity. This quarterly update reinforces the narrative of a robust but pricey franchise facing cyclical and structural challenges.

Implication

The decline in same-store sales growth from 5.5% to 3.3% quarter-over-quarter suggests weakening momentum, which could pressure future earnings if sustained amid industry competition and EV adoption trends. Persistent margin headwinds from LIFO and SG&A costs may hinder EPS expansion, making it harder for the company to justify its premium valuation multiples. With net debt/EBITDA at 2.85x and negative equity, the balance sheet remains vulnerable to operational setbacks, especially given aggressive, debt-funded share buybacks. Current valuation metrics, including a P/E of 22.3x and EV/EBITDA of 15.8, offer limited margin of safety compared to intrinsic value estimates, increasing downside risk in a market downturn. Therefore, the investment case remains unattractive at this price, and investors should await clearer signs of margin recovery or a meaningful stock pullback before considering an entry.

Thesis delta

The new quarterly data does not alter the core investment thesis; it confirms existing concerns about decelerating growth and margin pressures, reinforcing AutoZone's overvaluation and financial risks. While the company maintains strong fundamentals like high ROIC and cash flow, the lack of improvement in key watch items—valuation gaps and leverage—supports the continued 'WAIT' stance without a shift to buy or sell.